Koros C, Bougea A, Alefanti I, Simitsi A, Papagiannakis N, Pachi I
Genes (Basel). 2025; 15(12.
PMID: 39766872
PMC: 11675599.
DOI: 10.3390/genes15121605.
Ducatez F, Berger M, Pilon C, Plichet T, Lesueur C, Berger J
J Mol Med (Berl). 2024; 103(2):187-203.
PMID: 39738845
DOI: 10.1007/s00109-024-02512-x.
Pietrafesa D, Casamassa A, Benassi B, Santoro M, Marano M, Consales C
Int J Mol Sci. 2024; 25(21).
PMID: 39518995
PMC: 11870034.
DOI: 10.3390/ijms252111443.
Hertz E, Chen Y, Sidransky E
Nat Rev Neurol. 2024; 20(9):526-540.
PMID: 39107435
DOI: 10.1038/s41582-024-00999-z.
Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G
Int J Mol Sci. 2024; 25(13).
PMID: 39000225
PMC: 11241486.
DOI: 10.3390/ijms25137102.
Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy.
Walton S, Fenyi A, Tittle T, Sidransky E, Pal G, Choi S
NPJ Parkinsons Dis. 2024; 10(1):105.
PMID: 38773124
PMC: 11109094.
DOI: 10.1038/s41531-024-00679-1.
Neurological symptoms in adults with Gaucher disease: a systematic review.
Imbalzano G, Ledda C, Romagnolo A, Covolo A, Lopiano L, Artusi C
J Neurol. 2024; 271(7):3897-3907.
PMID: 38771384
PMC: 11233309.
DOI: 10.1007/s00415-024-12439-5.
Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson's disease.
Yuan Y, Wang Y, Liu M, Luo H, Liu X, Li L
Front Neurol. 2024; 15:1404492.
PMID: 38751879
PMC: 11094647.
DOI: 10.3389/fneur.2024.1404492.
Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease.
Dobert J, Bub S, Machtel R, Januliene D, Steger L, Regensburger M
Adv Sci (Weinh). 2024; 11(25):e2401641.
PMID: 38666485
PMC: 11220700.
DOI: 10.1002/advs.202401641.
Key genes and convergent pathogenic mechanisms in Parkinson disease.
Coukos R, Krainc D
Nat Rev Neurosci. 2024; 25(6):393-413.
PMID: 38600347
DOI: 10.1038/s41583-024-00812-2.
Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism.
Hertz E, Perez G, Hao Y, Rytel K, Ma C, Kirby M
bioRxiv. 2024; .
PMID: 38529501
PMC: 10962709.
DOI: 10.1101/2024.02.25.581985.
DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency.
Nam Y, Na J, Ma S, Park H, Park H, Lee E
Genes Genomics. 2024; 46(5):519-529.
PMID: 38460098
DOI: 10.1007/s13258-024-01506-w.
A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment.
Zhong W, Li D, Fei Y, Hong P
Acta Neurol Belg. 2024; 124(4):1213-1223.
PMID: 38413480
DOI: 10.1007/s13760-024-02493-1.
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease.
Furderer M, Berhe B, Chen T, Wincovitch S, Jiang X, Tayebi N
Int J Mol Sci. 2024; 25(3).
PMID: 38339105
PMC: 10855869.
DOI: 10.3390/ijms25031827.
Genetics in Parkinson's disease, state-of-the-art and future perspectives.
Trevisan L, Gaudio A, Monfrini E, Avanzino L, Di Fonzo A, Mandich P
Br Med Bull. 2024; 149(1):60-71.
PMID: 38282031
PMC: 10938543.
DOI: 10.1093/bmb/ldad035.
Pain in monogenic Parkinson's disease: a comprehensive review.
Alizadeh P, Terroba-Chambi C, Achen B, Bruno V
Front Neurol. 2023; 14:1248828.
PMID: 38020640
PMC: 10643218.
DOI: 10.3389/fneur.2023.1248828.
Neurological Insights into Sleep Disorders in Parkinson's Disease.
Thangaleela S, Sivamaruthi B, Kesika P, Mariappan S, Rashmi S, Choeisoongnern T
Brain Sci. 2023; 13(8).
PMID: 37626558
PMC: 10452387.
DOI: 10.3390/brainsci13081202.
Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives.
Mohamed W, Kumar J, Alghamdi B, Soliman A, Toshihide Y
IBRO Neurosci Rep. 2023; 14:95-110.
PMID: 37388502
PMC: 10300452.
DOI: 10.1016/j.ibneur.2022.12.003.
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial.
Chwiszczuk L, Breitve M, Kirsebom B, Selnes P, Flovig J, Knapskog A
Front Aging Neurosci. 2023; 15:1163184.
PMID: 37304077
PMC: 10250712.
DOI: 10.3389/fnagi.2023.1163184.
The loss of function GBA1 c.231C > G mutation associated with Parkinson disease.
Chen D, Zheng Y, Zhang G, Huang Y, Zheng B, Zhang J
J Neural Transm (Vienna). 2023; 130(7):905-913.
PMID: 37280314
DOI: 10.1007/s00702-023-02651-4.